Clinical Trials List
2009-07-01 - 2018-06-25
Phase III
Terminated6
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Yi-Hong Chou Division of Radiology
- 蘇正熙 Division of General Surgery
- Ta-Chung Chao Division of Hematology & Oncology
- Yi-Fang Tsai Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- YEN-SHEN LU Division of Hematology & Oncology
- MING-YANG WANG Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Fang-Ming Chen Division of General Surgery
- Fu Ouyang Division of General Surgery
- Chieh-Han Chuang Division of General Surgery
- 呂佳穎 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 沈士哲 Division of General Surgery
- Wen-Ling Kuo Division of General Surgery
- Yung-Chang Lin Division of General Surgery
- Hsien-Kun Chang Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 蔡伯邦 Division of General Surgery
- Chih-Jung Chen Division of General Surgery
- Yu-Min Liao Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- - - Division of Radiology
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
717 participants
